NORCET -4 , 2023
Obstetrics & Gynaecology
Medium

A pregnant woman at 28 weeks of gestation visited antenatal clinic at a primary health centre for the first time. Her hemoglobin level was found to be 9 gm%. The therapeutic management will include?

Appeared in: NORCET -4 , 2023

Explanation

  • A hemoglobin level of 9 gm% in a pregnant woman is classified as moderate anemia (normal range is 7.0-9.9 g/dL).
  • The recommended therapeutic dose for moderate anemia in pregnancy is 120 mg of elemental iron daily.
  • Since one standard IFA tablet contains 60 mg of elemental iron, two tablets are required daily to meet the therapeutic requirement.
  • This dosage is necessary to correct the anemia and replenish iron stores, supporting both maternal health and fetal development.

Why Other Options Were Wrong

  • Option A: This provides only 60 mg of elemental iron, which is the standard prophylactic (preventive) dose for non-anemic pregnant women. It is insufficient to treat existing moderate anemia.
  • Option B: Weekly iron supplementation is not the standard of care for treating anemia during pregnancy. This frequency is inadequate to correct an iron deficit in a pregnant woman.
  • Option D: Blood transfusion is an invasive procedure reserved for severe, life-threatening anemia (typically Hb below 7 g/dL) or in cases of acute hemorrhage or hemodynamic instability.

Related Visual

Visual explanation — Related Visual
  • Visual 1: Chart - A chart illustrating the classification of anemia in pregnancy (Mild, Moderate, Severe) based on hemoglobin levels. This helps visualize where the patient's value of 9 gm% falls.
  • Visual 2: Infographic - An infographic showing factors that enhance (e.g., Vitamin C) and inhibit (e.g., calcium, tannins in tea/coffee) iron absorption. This reinforces patient education points.
Clinical Relevance
  • Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Therapeutic management of moderate anemia in pregnancy as background academic context rather than a clinical decision trigger.
  • Nurses are central to managing anemia in pregnancy by screening patients, administering supplements, and providing crucial education on diet, compliance, and managing side effects.
  • Failure to treat moderate anemia can lead to significant maternal and fetal complications, including preterm birth, low birth weight, postpartum hemorrhage, and increased risk of infection.
  • What if? If the patient's hemoglobin was 11.2 g/dL, she would be considered non-anemic. The correct management would then be one IFA tablet daily as a prophylactic measure to prevent anemia from developing.
How to Approach the Question
  • First, identify the key clinical information provided in the stem: a pregnant woman at 28 weeks with a hemoglobin of 9 gm%.
  • Next, recall the classification of anemia during pregnancy. A hemoglobin level between 7.0 and 9.9 g/dL is defined as moderate anemia.
  • Differentiate between the prophylactic (preventive) and therapeutic (treatment) doses of iron. Prophylaxis is for all pregnant women, while therapy is for those diagnosed with anemia.
  • Recall the standard therapeutic dose of elemental iron for moderate anemia, which is 120 mg per day.
  • Calculate the number of tablets needed based on the strength provided in the options (60 mg elemental iron per tablet). 120 mg / 60 mg/tablet = 2 tablets.
  • Select the option that matches this calculation (2 tablets daily) and eliminate the others as either insufficient (1 tablet), incorrect frequency (weekly), or too aggressive (blood transfusion).
Concept Tested & Keywords
  • Concept Tested: Therapeutic management of moderate anemia in pregnancy.
  • Stem keywords: pregnant woman, 28 weeks gestation, hemoglobin 9 gm%, therapeutic management, IFA tablet
  • Lead-in keywords: will include
  • Clinical cues: 28 weeks gestation: This places the pregnancy at the beginning of the third trimester, a critical period for fetal growth and maternal health.
  • Clinical cues: Hemoglobin 9 gm%: This value is a key diagnostic indicator of moderate anemia, requiring therapeutic intervention rather than prophylaxis.

Question ID

QAmO1XHXJQ_FfTtPgR96Vt

Practise the full NORCET -4 , 2023

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Medical and Surgical Illness Complicating Pregnancy Questions

More NORCET -4 , 2023 Questions